Top

BMC Cancer

Published in:

Open Access 01-12-2021 | Research article

Prevalence of multimorbidity in adults with cancer, and associated health service utilization in Ontario, Canada: a population-based retrospective cohort study

Authors: Anna Péfoyo Koné, Deborah Scharf

Published in: BMC Cancer | Issue 1/2021

Abstract

Background

The majority of people with cancer have at least one other chronic health condition. With each additional chronic disease, the complexity of their care increases, as does the potential for negative outcomes including premature death. In this paper, we describe cancer patients’ clinical complexity (i.e., multimorbidity; MMB) in order to inform strategic efforts to improve care and outcomes for people with cancer of all types and commonly occurring chronic diseases.

Methods

We conducted a population-based, retrospective cohort study of adults diagnosed with cancer between 2003 and 2013 (N = 601,331) identified in Ontario, Canada healthcare administrative data. During a five to 15-year follow-up period (through March 2018), we identified up to 16 co-occurring conditions and patient outcomes for the cohort, including health service utilization and death.

Results

MMB was extremely common, affecting more than 91% of people with cancer. Nearly one quarter (23%) of the population had five or more co-occurring conditions. While we saw no differences in MMB between sexes, MMB prevalence and level increased with age. MMB prevalence and type of co-occurring conditions also varied by cancer type. Overall, MMB was associated with higher rates of health service utilization and mortality, regardless of other patient characteristics, and specific conditions differentially impacted these rates.

Conclusions

People with cancer are likely to have at least one other chronic medical condition and the presence of MMB negatively affects health service utilization and risk of premature death. These findings can help motivate and inform health system advances to improve care quality and outcomes for people with cancer and MMB.

Available only for authorised users

Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet. 2012;380(9836):37–43%U https://linkinghub.elsevier.com/retrieve/pii/S0140673612602402.

Boyd CM, Fortin M. Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design? Public Health Reviews. 2010;32(2):451–74%U http://publichealthreviews.biomedcentral.com/articles/10.1007/BF03391611.

Feely A, Lix LM, Reimer K. Estimating multimorbidity prevalence with the Canadian chronic disease surveillance system. Health Promot Chronic Dis Prev Can. 2017;37(7):215–22. https://doi.org/10.24095/hpcdp.37.7.02.CrossRefPubMed

Koné Pefoyo AJ, Bronskill SE, Gruneir A, Calzavara A, Thavorn K, Petrosyan Y, et al. The increasing burden and complexity of multimorbidity. BMC Public Health. 2015;15(1%U http://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-015-1733-2).

St John PD, Tyas SL, Menec V, Tate R. Multimorbidity, disability, and mortality in community-dwelling older adults. Canadian Family Physician Medecin De Famille Canadien. 2014;60(5):e272–80.PubMedPubMedCentral

Salako O, Okediji PT, Habeebu MY, Fatiregun OA, Awofeso OM, Okunade KS, et al. The pattern of comorbidities in cancer patients in Lagos, South-Western Nigeria. Ecancermedicalscience. 2018;12:843.CrossRef

Leach CR, Weaver KE, Aziz NM, Alfano CM, Bellizzi KM, Kent EE, et al. The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv. 2015;9(2):239–51. https://doi.org/10.1007/s11764-014-0403-1.CrossRefPubMed

Ng HS, Roder D, Vitry A. Prevalence of Comorbidities and Health Status among Current Cancer and Cancer Survivors: An Australian Population-Based Study.: Value in Health; 2016.

Glynn LG, Valderas JM, Healy P, Burke E, Newell J, Gillespie P, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011;28(5):516–23. https://doi.org/10.1093/fampra/cmr013.CrossRefPubMed

10.

Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition--multimorbidity. JAMA. 2012;307(23):2493–4. https://doi.org/10.1001/jama.2012.5265.CrossRefPubMedPubMedCentral

11.

Fowler H, Belot A, Ellis L, Maringe C, Luque-Fernandez MA, Njagi EN, et al. Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers. BMC Cancer. 2020;20(1):2. https://doi.org/10.1186/s12885-019-6472-9.CrossRefPubMedPubMedCentral

12.

Boakye D, Rillmann B, Walter V, Jansen L, Hoffmeister M, Brenner H. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: a systematic review and meta-analysis. Cancer Treat Rev. 2018;64:30–9. https://doi.org/10.1016/j.ctrv.2018.02.003.CrossRefPubMed

13.

Ayeni OA, Norris SA, Joffe M, Cubasch H, Nietz S, Buccimazza I, et al. The multimorbidity profile of south African women newly diagnosed with breast cancer. Int J Cancer. 2020;147(2):361–74. https://doi.org/10.1002/ijc.32727.CrossRefPubMed

14.

Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME. Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc. 2006;54(12):1898–904. https://doi.org/10.1111/j.1532-5415.2006.00973.x.CrossRefPubMed

15.

Stairmand J, Signal L, Sarfati D, Jackson C, Batten L, Holdaway M, et al. Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: a systematic review. Ann Oncol. 2015;26(7):1325–32. https://doi.org/10.1093/annonc/mdv025.CrossRefPubMed

16.

Gurney J, Sarfati D, Stanley J. The impact of patient comorbidity on cancer stage at diagnosis. Br J Cancer. 2015;113(9):1375–80. https://doi.org/10.1038/bjc.2015.355.CrossRefPubMedPubMedCentral

17.

Dima S, Chen KH, Wang KJ, Wang KM, Teng NC. Effect of comorbidity on lung Cancer diagnosis timing and mortality: a Nationwide population-based cohort study in Taiwan. Biomed Res Int. 2018;2018:1252897.CrossRef

18.

Ritchie CS, Kvale E, Fisch MJ. Multimorbidity: an issue of growing importance for oncologists. J Oncol Pract. 2011;7(6):371–4. https://doi.org/10.1200/JOP.2011.000460.CrossRefPubMedPubMedCentral

19.

Sharma M, Loh KP, Nightingale G, Mohile SG, Holmes HM. Polypharmacy and potentially inappropriate medication use in geriatric oncology. J Geriatr Oncol. 2016;7(5):346–53. https://doi.org/10.1016/j.jgo.2016.07.010.CrossRefPubMedPubMedCentral

20.

Morio K, Maeda I, Yokota I, Niki K, Murata T, Matsumura Y, et al. Risk factors for Polypharmacy in elderly patients with Cancer pain. Am J Hosp Palliat Care. 2019;36(7):598–602. https://doi.org/10.1177/1049909118824031.CrossRefPubMed

21.

Chen RC, Royce TJ, Extermann M, Reeve BB. Impact of age and comorbidity on treatment and outcomes in elderly cancer patients. Semin Radiat Oncol. 2012;22(4):265–71. https://doi.org/10.1016/j.semradonc.2012.05.002.CrossRefPubMed

22.

Janssen-Heijnen ML, Maas HA, Houterman S, Lemmens VE, Rutten HJ, Coebergh JW. Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer. 2007;43(15):2179–93. https://doi.org/10.1016/j.ejca.2007.06.008.CrossRefPubMed

23.

Søgaard M, Thomsen RW, Bossen KS, Sørensen HT, Nørgaard M. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2013;5(Suppl 1):3–29. https://doi.org/10.2147/CLEP.S47150.CrossRefPubMedPubMedCentral

24.

Gross CP, McAvay GJ, Guo Z, Tinetti ME. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer. 2007;109(12):2410–9. https://doi.org/10.1002/cncr.22726.CrossRefPubMed

25.

Wojciechowska J, Krajewski W, Bolanowski M, Kręcicki T, Zatoński T. Diabetes and Cancer: a review of current knowledge. Exp Clin Endocrinol Diabetes. 2016;124(5):263–75. https://doi.org/10.1055/s-0042-100910.CrossRefPubMed

26.

Gironés R, Torregrosa D, Gómez-Codina J, Maestu I, Tenias JM, Rosell R. Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians. Clin Transl Oncol. 2012;14(3):183–9. https://doi.org/10.1007/s12094-012-0782-6.CrossRefPubMed

27.

Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–76. https://doi.org/10.1001/archinte.162.20.2269.CrossRefPubMed

28.

Koroukian SM, Bakaki PM, Schluchter MD, Owusu C. Treatment and survival patterns in relation to multimorbidity in patients with locoregional breast and colorectal cancer. J Geriatr Oncol. 2011;2(3):200–8. https://doi.org/10.1016/j.jgo.2011.02.004.CrossRefPubMedPubMedCentral

29.

Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16(12):1231–72. https://doi.org/10.1016/S1470-2045(15)00205-3.CrossRefPubMed

30.

Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29(3):725–31. https://doi.org/10.2337/diacare.29.03.06.dc05-2078.CrossRefPubMed

31.

Sussman J, Baldwin LM. The interface of primary and oncology specialty care: from diagnosis through primary treatment. J Natl Cancer Inst Monogr. 2010;2010(40):18–24. https://doi.org/10.1093/jncimonographs/lgq007.CrossRefPubMedPubMedCentral

32.

Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians' views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27(20):3338–45. https://doi.org/10.1200/JCO.2008.20.4883.CrossRefPubMed

33.

Potosky AL, Han PK, Rowland J, Klabunde CN, Smith T, Aziz N, et al. Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med. 2011;26(12):1403–10. https://doi.org/10.1007/s11606-011-1808-4.CrossRefPubMedPubMedCentral

34.

Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. BMJ. 2015;350(jan20 2):h176. https://doi.org/10.1136/bmj.h176.CrossRefPubMed

35.

Lee S, Rothbard A, Choi S. Effects of comorbid health conditions on healthcare expenditures among people with severe mental illness. J Ment Health. 2016;25(4):291–6. https://doi.org/10.3109/09638237.2015.1101420.CrossRefPubMed

36.

Coleman EA. Falling through the cracks: challenges and opportunities for improving transitional care for persons with continuous complex care needs. J Am Geriatr Soc. 2003;51(4):549–55. https://doi.org/10.1046/j.1532-5415.2003.51185.x.CrossRefPubMed

37.

Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases--a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci. 2011;66(3):301–11.CrossRef

38.

Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10(2):142–51. https://doi.org/10.1370/afm.1337.CrossRefPubMedPubMedCentral

39.

National Cancer Institute. SEER Site Recode ICD-O-3 (1/27/2003) Definition [Available from: https://seer.cancer.gov/siterecode/icdo3_d01272003/.

40.

Leung KM, Elashoff RM, Afifi AA. Censoring issues in survival analysis. Annu Rev Public Health. 1997;18(1):83–104. https://doi.org/10.1146/annurev.publhealth.18.1.83.CrossRefPubMed

41.

Koné PA, Mondor L, Maxwell C, Kabir US, Rosella L, Wodchis WP. Rising burden of multimorbidity and related socio-demographic factors: a repeated cross-sectional study of Ontarians. Canadian Journal of Public Health. 2021 (accepted).

42.

Katikireddi SV, Skivington K, Leyland AH, Hunt K, Mercer SW. The contribution of risk factors to socioeconomic inequalities in multimorbidity across the lifecourse: a longitudinal analysis of the Twenty-07 cohort. BMC Medicine. 2017;15(1%U http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0913-6).

43.

Canizares M, Hogg-Johnson S, Gignac MAM, Glazier RH, Badley EM. Increasing Trajectories of Multimorbidity Over Time: Birth Cohort Differences and the Role of Changes in Obesity and Income. The Journals of Gerontology: Series B. 2018;73(7):1303–14%U https://academic.oup.com/psychsocgerontology/article/73/7//2990202.

44.

Ontario CC. Cervical Screening [Available from: https://www.cancercareontario.ca/en/types-of-cancer/cervical/screening#:~:text=When%20to%20Get%20Screened.%20The%20Ontario%20Cervical%20Screening,by%20a%20doctor%20or%20nurse%20practitioner%20to%20stop.

45.

Seigneurin A, Delafosse P, Trétarre B, Woronoff AS, Velten M, Grosclaude P, et al. Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries. BMC Cancer. 2018;18(1):1091. https://doi.org/10.1186/s12885-018-5000-7.CrossRefPubMedPubMedCentral

46.

Legler A, Bradley EH, Carlson MD. The effect of comorbidity burden on health care utilization for patients with cancer using hospice. J Palliat Med. 2011;14(6):751–6. https://doi.org/10.1089/jpm.2010.0504.CrossRefPubMedPubMedCentral

47.

Druss BG, Marcus SC, Olfson M, Pincus HA. The most expensive medical conditions in America. Health Aff (Millwood). 2002;21(4):105–11. https://doi.org/10.1377/hlthaff.21.4.105.CrossRef

48.

Muggah E, Graves E, Bennett C, Manuel DG. Ascertainment of chronic diseases using population health data: a comparison of health administrative data and patient self-report. BMC Public Health. 2013;13(1):16. https://doi.org/10.1186/1471-2458-13-16.CrossRefPubMedPubMedCentral

49.

Gruneir A, Griffith LE, Fisher K, Perez R, Favotto L, Patterson C, et al. Measuring multimorbidity series. An overlooked complexity - comparison of self-report vs. administrative data in community-living adults: paper 3. Agreement across data sources and implications for estimating associations with health service use. J Clin Epidemiol. 2020;124:173–82. https://doi.org/10.1016/j.jclinepi.2020.04.018.CrossRefPubMed

50.

Verheij RA, Curcin V, Delaney BC, McGilchrist MM. Possible sources of Bias in primary care electronic health record data use and reuse. J Med Internet Res. 2018;20(5):e185. https://doi.org/10.2196/jmir.9134.CrossRefPubMedPubMedCentral

51.

Davis KA, Sudlow CL, Hotopf M. Can mental health diagnoses in administrative data be used for research? A systematic review of the accuracy of routinely collected diagnoses. BMC Psychiatry. 2016;16:263.CrossRef

52.

Vin-Raviv N, Akinyemiju TF, Galea S, Bovbjerg DH. Depression and anxiety disorders among hospitalized women with breast Cancer. PLoS One. 2015;10(6):e0129169. https://doi.org/10.1371/journal.pone.0129169.CrossRefPubMedPubMedCentral

53.

Terret C, Castel-Kremer E, Albrand G, Droz JP. Effects of comorbidity on screening and early diagnosis of cancer in elderly people. Lancet Oncol. 2009;10(1):80–7. https://doi.org/10.1016/S1470-2045(08)70336-X.CrossRefPubMed

54.

Stewart M, Fortin M. Team* P-CIfPwM. Patient-Centred innovations for persons with multimorbidity: funded evaluation protocol. CMAJ Open. 2017;5(2):E365–E72. https://doi.org/10.9778/cmajo.20160097.CrossRefPubMedPubMedCentral

Title: Prevalence of multimorbidity in adults with cancer, and associated health service utilization in Ontario, Canada: a population-based retrospective cohort study
Authors: Anna Péfoyo Koné
Deborah Scharf
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-021-08102-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Intraoperative radiation therapy induces immune response activity after pancreatic surgery

Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria

Clinical significance of the cachexia index in patients with small cell lung cancer

Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains

The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis

Association of neutrophil-to-lymphocyte ratio with severe radiation-induced mucositis in pharyngeal or laryngeal cancer patients: a retrospective study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer